3rd Quarter - Report — HARM REDUCTION COALITION for HARM REDUCTION COALITION (2013)

Firm

HARM REDUCTION COALITION

Client

HARM REDUCTION COALITION

Income

$20,000

Expenses

—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Alcohol and Drug Abuse ALC

Overdose prevention Syringe exchange services Addiction treatment access

Lobbyist	Covered position, as disclosed
WHITNEY ENGLANDER	—

Contacted: Centers For Disease Control & Prevention (CDC); Food & Drug Administration (FDA); Office of Management & Budget (OMB); HOUSE OF REPRESENTATIVES; Office of Natl Drug Control Policy (NDCP); SENATE

Health Issues HCR

Viral hepatitis testing and treatment access

Lobbyist	Covered position, as disclosed
WHITNEY ENGLANDER	—

Contacted: Food & Drug Administration (FDA); Office of Natl Drug Control Policy (NDCP); SENATE; Office of Management & Budget (OMB); Centers For Disease Control & Prevention (CDC); HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.